BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37999132)

  • 21. [Cutaneous lymphomas : Clinical presentation - diagnosis - treatment].
    Wobser M; Goebeler M
    Hautarzt; 2019 Oct; 70(10):815-830. PubMed ID: 31511903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
    Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
    Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognosis of primary cutaneous lymphomas].
    Grange F; Bagot M
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):30-40. PubMed ID: 11937927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis.
    Stoll JR; Willner J; Oh Y; Pulitzer M; Moskowitz A; Horwitz S; Myskowski P; Noor SJ
    J Am Acad Dermatol; 2021 Nov; 85(5):1073-1090. PubMed ID: 33940098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatric Primary Cutaneous Lymphoma in China: A Retrospective Study.
    Zhang C; Jiang Y; Xu X; Sun J; Chen H
    Dermatology; 2023; 239(4):553-564. PubMed ID: 37231916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM; Cerroni L
    Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part II: Prognosis and management.
    Oh Y; Stoll JR; Moskowitz A; Pulitzer M; Horwitz S; Myskowski P; Noor SJ
    J Am Acad Dermatol; 2021 Nov; 85(5):1093-1106. PubMed ID: 33945836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous lymphomas with prominent granulomatous reaction: a potential pitfall in the histopathologic diagnosis of cutaneous T- and B-cell lymphomas.
    Scarabello A; Leinweber B; Ardigó M; Rütten A; Feller AC; Kerl H; Cerroni L
    Am J Surg Pathol; 2002 Oct; 26(10):1259-68. PubMed ID: 12360040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy of cutaneous lymphoma--current practice and future developments.
    Dummer R; Kempf W; Hess Schmid M; Häffner A; Burg G
    Onkologie; 2003 Aug; 26(4):366-72. PubMed ID: 12972705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary cutaneous lymphomas: a population-based descriptive study of 71 consecutive cases diagnosed between 1980 and 2003.
    Riou-Gotta MO; Fournier E; Mermet I; Pelletier F; Humbert P; Danzon A; Aubin F
    Leuk Lymphoma; 2008 Aug; 49(8):1537-44. PubMed ID: 18766967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of cutaneous lymphomas in a medical center in Bahia, Brazil.
    Bittencourt AL; Oliveira PD; Andrade AC; Santos TC; Oliveira RF; Farré L; Araujo I
    Am J Clin Pathol; 2013 Sep; 140(3):348-54. PubMed ID: 23955453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of classic architectural criteria in non-mycosis fungoides cutaneous lymphomas.
    Glusac EJ; Kindel SE; Soslow RA; Smoller BR
    Am J Dermatopathol; 1997 Dec; 19(6):557-61. PubMed ID: 9415610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary cutaneous medium and large cell lymphomas other than mycosis fungoides. An immunohistological and follow-up study on 54 cases. French Study Group for Cutaneous Lymphomas.
    Joly P; Vasseur E; Esteve E; Leibowitch M; Tilly H; Vaillant L; Wechsler J; Thomine E; De Muret A; Dreyfus F
    Br J Dermatol; 1995 Apr; 132(4):506-12. PubMed ID: 7748738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.
    Neelis KJ; Schimmel EC; Vermeer MH; Senff NJ; Willemze R; Noordijk EM
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):154-8. PubMed ID: 18834672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eyelid involvement of primary cutaneous lymphomas: A clinical perspective.
    Baykal C; Atci T
    Australas J Dermatol; 2023 Nov; 64(4):463-475. PubMed ID: 37435706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pediatric Cutaneous Hematologic Disorders: Cutaneous Lymphoma and Leukemia Cutis-Experience of a Tertiary-Care Pediatric Institution and Review of the Literature.
    Colmant C; Demers MA; Hatami A; Coulombe J; McCuaig CC; Piram M; Marcoux D; Kokta V; Powell J
    J Cutan Med Surg; 2022; 26(4):349-360. PubMed ID: 35167768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnostics of primary cutaneous lymphomas].
    Felcht M; Hillen U; Klemke CD
    Hautarzt; 2017 Sep; 68(9):696-701. PubMed ID: 28779267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary cutaneous lymphomas: single center experience of dermatology and hematology clinics.
    Payzin B; Ogretmen Z; Cidem Yildirim A; Ozturk Durur S; Sentekin S
    J BUON; 2014; 19(1):171-7. PubMed ID: 24659660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.